| Association of cutaneous immune-related adverse events with increased survival in patients treated with anti–programmed cell death 1 and anti–programmed cell death ligand 1 therapy K Tang, J Seo, BC Tiu, TK Le, V Pahalyants, NS Raval, PO Ugwu-Dike, ... JAMA dermatology 158 (2), 189-193, 2022 | 84 | 2022 |
| CBP/p300 acetyltransferase activity in hematologic malignancies R Dutta, B Tiu, KM Sakamoto Molecular genetics and metabolism 119 (1-2), 37-43, 2016 | 77 | 2016 |
| Small molecule inhibition of cAMP response element binding protein in human acute myeloid leukemia cells B Mitton, HD Chae, K Hsu, R Dutta, G Aldana-Masangkay, R Ferrari, ... Leukemia 30 (12), 2302-2311, 2016 | 43 | 2016 |
| Real-world incidence and impact of pneumonitis in patients with lung cancer treated with immune checkpoint inhibitors: a multi-institutional cohort study BC Tiu, L Zubiri, J Iheke, V Pahalyants, N Theodosakis, P Ugwu-Dike, ... Journal for immunotherapy of cancer 10 (6), 2022 | 35 | 2022 |
| RSK inhibitor BI-D1870 inhibits acute myeloid leukemia cell proliferation by targeting mitotic exit HD Chae, R Dutta, B Tiu, FW Hoff, B Accordi, V Serafin, M Youn, M Huang, ... Oncotarget 11 (25), 2387, 2020 | 17 | 2020 |
| Pre-existing autoimmune disease and mortality in patients treated with anti-PD-1 and anti-PD-L1 therapy K Tang, BC Tiu, G Wan, S Zhang, N Nguyen, B Leung, A Gusev, ... Journal of the National Cancer Institute 114 (8), 1200-1202, 2022 | 14 | 2022 |
| On defining global catastrophic biological risks MJ Palmer, BC Tiu, AS Weissenbach, DA Relman Health security 15 (4), 347-348, 2017 | 13 | 2017 |
| Safety of immune checkpoint inhibitors in patients with advanced chronic kidney disease: A retrospective cohort study BC Tiu, IA Strohbehn, S Zhao, T Ouyang, P Hanna, Q Wang, S Gupta, ... The Oncologist 28 (6), e379-e390, 2023 | 7 | 2023 |
| A comprehensive review of DOACs for cancer associated VTE prophylaxis or treatment EJ Brea, BC Tiu, JM Connors Postgraduate Medicine 133 (sup1), 71-79, 2021 | 7 | 2021 |
| Small molecule screen for inhibitors of expression from canonical CREB response element-containing promoters B Mitton, K Hsu, R Dutta, BC Tiu, N Cox, KG McLure, HD Chae, M Smith, ... Oncotarget 7 (8), 8653, 2016 | 7 | 2016 |
| Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: rationale and methodology of the CORONA … B Bikdeli, CD Khairani, D Krishnathasan, A Bejjani, A Armero, A Tristani, ... Thrombosis Research 228, 94-104, 2023 | 5 | 2023 |
| Biotechnology Risk Assessment: State of the Field GD Koblentz, J Kirkpatrick, MJ Palmer, SW Denton, B Tiu, K Kelsey George Mason University, 2017 | 3 | 2017 |
| RSK inhibition suppresses AML proliferation through activation of DNA damage pathways and S phase arrest R Dutta, M Castellanos, B Tiu, HD Chae, KL Davis, KM Sakamoto Blood, The Journal of the American Society of Hematology 128 (22), 2894-2894, 2016 | 3 | 2016 |
| CREB increases chemotherapy resistance through regulation of the DNA damage repair pathway in AML cells R Dutta, B Tiu, A Kaul, B Mitton, KM Sakamoto Blood 126 (23), 1390, 2015 | 3 | 2015 |
| Patterns in utilization of health care services and medications among patients with cutaneous immune-related adverse events: a population-level cohort study BW Leung, MR Collier, BC Tiu, G Wan, N Nguyen, K Tang, S Zhang, ... Journal of the American Academy of Dermatology 88 (5), 1215-1218, 2023 | 2 | 2023 |
| RSK Inhibition Induces Metaphase Arrest and Apoptosis in Acute Myeloid Leukemia Cells HD Chae, R Dutta, B Tiu, KL Davis, NJ Lacayo, KM Sakamoto Blood 130, 2530, 2017 | 2 | 2017 |
| Low absolute risk of thrombotic and cardiovascular events in outpatient pregnant women with COVID-19 B Bikdeli, D Krishnathasan, CD Khairani, A Bejjani, J Davies, N Porio, ... Thrombosis Research 237, 209-215, 2024 | | 2024 |
| Ninety-Day Thrombotic Events in Patients With COVID-19, Association With Vaccination Status, and Changes Over Time: The Corona-VTE Network Study B Bikdeli, D Krishnathasan, A Bejjani, CD Khairani, ND Porio, J Davies, ... Circulation 148 (Suppl_1), A17282-A17282, 2023 | | 2023 |
| Ninety-Day Adjudicated Cardiovascular Events in Patients With Covid-19: Association With Vaccination Status and Changes Over Time in the Corona-VTE Network Study B Bikdeli, A Bejjani, CD Khairani, D Krishnathasan, J Davies, ND Porio, ... Circulation 148 (Suppl_1), A17286-A17286, 2023 | | 2023 |
| Adjudicated cardiovascular events in a cotemporary multicenter cohort of patients with COVID-19: findings from the CORONA-VTE Registry B Bikdeli, D Krishnathasan, CD Khairani, A Bejjani, A Tristani, N Porio, ... European Heart Journal 44 (Supplement_2), ehad655. 1223, 2023 | | 2023 |
